
|Videos|July 31, 2023
Evolving Management of EGFR Exon20+ NSCLC: Future Directions in Care
Author(s)Joshua K. Sabari, MD, Misako Nagasaka, MD
Closing out their discussion on EGFR Exon20+ non–small cell lung cancer, Joshua Sabari, MD, and Misako Nagasaka, MD, share excitement for future evolutions in the treatment paradigm.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Revolutionizing Oncology in the Digital Age: Effects on Health Care Providers
2
3 Things You Should Know About Frontline and Maintenance Therapy for HER2+ Metastatic Breast Cancer
3
How Do You Choose The Right Frontline Therapy in CLL Care?
4
Exploring The Future of Artificial Intelligence and Thoracic Oncology
5
















































































